110 related articles for article (PubMed ID: 6751032)
1. Possible role of dipeptidyl carboxypeptidase n the metabolism of Met5-enkephalin and Met5-enkephalin-Arg6-Phe7.
Yang HY; Harsing LG; Majane EM; Costa E
Adv Biochem Psychopharmacol; 1982; 33():251-60. PubMed ID: 6751032
[No Abstract] [Full Text] [Related]
2. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception.
Chou J; Tang J; Del Rio J; Yang HY; Costa E
J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138
[TBL] [Abstract][Full Text] [Related]
3. Substrate- and inhibitor-specificity of a non-endothelial enzyme which forms [Met5]-enkephalin from [Met5]-enkephalin-Arg6,Phe7 in isolated rabbit ear artery: pharmacological characterization.
Rónai AZ; Fehér E; Botyánszki J; Hepp J; Magyar A; Medzihradszky K
Neuropeptides; 1995 Mar; 28(3):137-45. PubMed ID: 7791957
[TBL] [Abstract][Full Text] [Related]
4. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors.
Zhang AZ; Yang HY; Costa E
Neuropharmacology; 1982 Jul; 21(7):625-30. PubMed ID: 6750433
[TBL] [Abstract][Full Text] [Related]
5. Increase of striatal Met5-enkephalin-Arg6-Phe7 (YGGFMRF) content elicited by long-term treatment with haloperidol.
Chou J; Tang J; Yang HY; Costa E
J Pharmacol Exp Ther; 1984 Apr; 229(1):171-4. PubMed ID: 6368796
[TBL] [Abstract][Full Text] [Related]
6. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens.
Blum K; Wallace JE; DeLallo L; Briggs AH
Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556
[TBL] [Abstract][Full Text] [Related]
7. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T
J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
Norman JA; Autry WL; Barbaz BS
Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497
[TBL] [Abstract][Full Text] [Related]
9. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
Reggiani A; Carenzi A; Frigeni V; Della Bella D
Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
[TBL] [Abstract][Full Text] [Related]
10. The effect of peptidase inhibitors on the release of Met5-Enk-Arg6-Phe7 (YGGFMRF) and Met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo.
Tang J; Chou J; Yang HY; Costa E
Life Sci; 1983; 33 Suppl 1():121-4. PubMed ID: 6198574
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of [Met5]enkephalin semicarbazide is not affected by dipeptidyl carboxypeptidase-I.
Rezaee Z; Arabanian SA; Balalaie S; Ahmadiani A; Khalaj L; Nasoohi S
J Pept Sci; 2012 Feb; 18(2):92-6. PubMed ID: 22083687
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
Mellstrom B; Iadarola MJ; Yang HY; Costa E
J Pharmacol Exp Ther; 1986 Oct; 239(1):174-8. PubMed ID: 2945003
[TBL] [Abstract][Full Text] [Related]
13. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan.
Hiranuma T; Oka T
Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of enkephalins degradation in the nucleus accumbens leads to potentiation of acupuncture and morphine analgesia].
Jin WQ; Zhou ZF; Han JS
Sheng Li Xue Bao; 1985 Aug; 37(4):377-82. PubMed ID: 3915599
[No Abstract] [Full Text] [Related]
16. Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception.
Mellstrom B; Iadarola MJ; Costa E
Eur J Pharmacol; 1987 Jan; 133(2):185-90. PubMed ID: 2949992
[TBL] [Abstract][Full Text] [Related]
17. Conversion of [met5]-enkephalin-Arg6-Phe7 to [met5]-enkephalin by dipeptidyl carboxypeptidase.
Yang HY; Majane E; Costa E
Neuropharmacology; 1981 Sep; 20(9):891-4. PubMed ID: 7027075
[No Abstract] [Full Text] [Related]
18. Estimation of relative importance of three enzymes in the inactivation of [Met5]-enkephalin and [Met5]-enkephalin-Arg6 in three isolated preparations by employing the inhibitor specific for each enzyme.
Kuno Y; Oka T
Jpn J Pharmacol; 1987 Jul; 44(3):241-7. PubMed ID: 2821306
[TBL] [Abstract][Full Text] [Related]
19. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948
[TBL] [Abstract][Full Text] [Related]
20. The heptapeptide Met-enkephalin-Arg6, Phe7 is released from rat striatum in vitro by high potassium.
Patey G; Cupo A; Giraud P; Chaminade M; Rossier J
Neurosci Lett; 1983 Jun; 37(3):267-71. PubMed ID: 6310454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
